DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Wednesday 26 August 2015

Tetratopic pyrimidine–hydrazone ligands

.




The first tetratopic pyrimidine–hydrazone (pym–hyz) molecular strands containing terminal hydroxymethyl (L1) and acryloyl (L2) functional groups have been synthesised. L1 was produced by step-wise imine condensation reactions, starting with 6-hydroxymethyl-2-pyridinecarboxaldehyde. L2 was then synthesised through the treatment of L1 with acryloyl chloride. NMR spectroscopy and X-ray crystallography showed that the ligands adopted a helical shape, comprised of 1 and 1/3 helical turns. Both L1 and L2 uncoiled upon reaction with an excess amount of Pb(II), Zn(II) and Cu(II) ions, resulting in linear M4LA8 complexes (where M = Pb(II), Zn(II), or Cu(II); L = L1 or L2; and A = ClO4, SO3CF3 or BF4). Horse-shoe shaped Pb2LA4 complexes were also formed by reacting Pb(II) ions with either L1 or L2 in a 2 : 1 metal to ligand ratio. The addition of Ag(I) ions to either L1 or L2 resulted in Ag2L2A2 double helicates, which were stable in the presence of excess Ag(I). The Pb(II), Zn(II) and Ag(I) complexes were characterised by NMR spectroscopy, while UV-Vis spectroscopy was used to probe the Cu(II) complexes. In addition, X-ray crystallography was used to analyse the linear Pb4L1A8, horse-shoe shaped Pb2L1(ClO4)4, twisted Cu3L2(SO3CF3)6, and double helicate Ag2L12(SO3CF3)2 complexes yielding the structures [Pb4L1(ClO4)7(H2O)]ClO4·4CH3NO2 (1), [Pb4L1(SO3CF3)8]2·6CH3CN·H2O (2), [Pb2L1(ClO4)2(CH3CN)(H2O)](ClO4)2·2CH3CN·C4H10O·H2O (3), [Cu3L2(SO3CF3)3(CH3CN)2(H2O)](SO3CF3)3·2CH3CN·H2O (4) and [Ag2L12](SO3CF3)2·CH3CN·H2O (5), respectively.


Graphical abstract: Tetratopic pyrimidine–hydrazone ligands modified with terminal hydroxymethyl and acryloyl arms and their Pb(ii), Zn(ii), Cu(ii) and Ag(i) complexes 
 
 

Tetratopic pyrimidine–hydrazone ligands modified with terminal hydroxymethyl and acryloyl arms and their Pb(II), Zn(II), Cu(II) and Ag(I) complexes

*Corresponding authors
aDepartment of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
E-mail: lhanton@chemistry.otago.ac.nz
Dalton Trans., 2014,43, 8205-8218

DOI: 10.1039/C3DT53559B

// http://pubs.rsc.org/en/content/articlelanding/2014/dt/c3dt53559b#!divAbstract

No comments:

Post a Comment